Discussions also delved into the complexities of value-based oncology care, the growing role of real-world data, and strategies to improve access to care in hematology. Across all sessions, a common ...

Strong government Investments and Precision medicine Propel Growth in Sanger Sequencing Market, Expected to Quadruple Its Size Over the Next Decade ...

The age of targeted cancer therapies brings the potential for more treatment options, greater effectiveness and fewer side effects.

A person's lifetime risk for cancer may begin before they are even born, reports a paradigm-shifting study by Van Andel Institute scientists.

In this article, Momin Shah discusses how to ensure that NGS protocols are optimized from the outset to save time and costs ...

The oncology field is experiencing a profound shift due to the rapid integration of artificial intelligence (AI) and machine ...

Functional genomics can help deconvolute the link between genotype and phenotype in disease, revealing new drug targets and ...

As the percentage of the global population over 65 continues to increase, the popularity of anti-aging stocks is rising in ...

Advances in CRISPR technologies promise to accelerate the burgeoning pipeline of gene-editing therapies and broaden access to these disease-altering therapies.

The global cancer biopsy market size was valued at USD 30.96 billion in 2024 and is estimated to reach from USD 33.38 billion ...

The medical device industry is at the forefront of innovation, transforming healthcare delivery through groundbreaking technologies. At the center of this progress are life science innovations, which ...

The genomic urine testing industry in the United States is predicted to reach USD 66.3 million by 2033, increasing at a 4.9% ...